-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $20

Benzinga·05/12/2026 11:59:48
Listen to the news
Benchmark analyst Bruce Jackson initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $20.